Search Results 541-550 of 17277 for Aldosterone

1. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   This is a multicenter, double-blind, randomized, placebo-controlled trial involving subjects with a diagnosis of "definite NASH" with fibrosis (excluding ...

2. Atrial fibrillation - Doctors and departments - Mayo Clinic

   A fast, pounding heartbeat could be due to AFib, a type of heart rhythm disorder. Know the warning signs and when treatment is needed.

3. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

4. Cardiovascular Medicine - Clinical trials

   Rochester, Minn. Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is ...

5. Cardiovascular Medicine - Clinical trials

   Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...

6. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

   Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

7. Heart disease - Request an appointment - Mayo Clinic

   Learn about symptoms, causes and treatment of cardiovascular disease, a term describing a wide range of conditions that can affect the heart.

8. Drugs and Supplements that Start with V - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “V” to learn about drug side effects, proper use and ...

9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

10. Spasticity management for spinal cord injury - Doctors & Departments - Mayo Clinic

    Muscle overactivity can be a side effect of spinal cord injury or illness. Treatment may include physical therapy, medicine or surgery.